Analysis of clinical features, serologic and cerebrospinal fluid tests in patients with neurosyphilis at different stages

Bao-jie WANG, Chun-juan WANG, Hao SUN, Shou-gang GUO

Abstract


Objective To summarize the clinical features, serologic, cerebrospinal fluid (CSF) tests in patients with neurosyphilis at different stages.  Methods A retrospective analysis was made on the clinical features, imaging, serologic and CSF tests, treatment and prognosis of 12 cases diagnosed as neurosyphilis. In those cases, 5 cases were early-stage neurosyphilis, including 4 syphilitic meningitis (meningomyelitis) and one meningovascular syphilis; 7 cases were late-stage neurosyphilis, all of whom were general paresis.  Results The serum Treponema pallidum antibody (TP-Ab) and rapid plasma regain (RPR) tests were positive in all 12 cases. The CSF TP-Ab tests of 12 cases were all positive and CSF RPR tests were positive in 9 cases. In 5 cases of early-stage neurosyphilis, one case had elevated intracranial pressure (ICP), 3 cases presented with elevated white blood cell (WBC), 4 cases had elevated protein concentration. In 7 cases of late-stage neurosyphilis, one case had elevated ICP, 7 cases presented with elevated WBC and protein concentration. CSF cytology showed lymphocyte reaction, mainly small lymphocytes. All cases were treated with different doses of intravenous penicillin or ceftriaxone sodium by intramuscular injection, among whom 8 cases presented improved neuropsychiatric symptoms, while 4 cases had no significant improvement.  Conclusions Neurosyphilis is easy to be misdiagnosed because of various styles of onset and nontypical clinical manifestations. A definite diagnosis depends on clinical manifestations and serologic and CSF examinations. Early diagnosis and standard treatment is essential for improving prognosis and reducing complications.

 

DOI: 10.3969/j.issn.1672-6731.2016.07.005


Keywords


Neurosyphilis; Serologic tests; Cerebrospinal fluid

Full Text: PDF

Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.